About Ankara University Medical Faculty Cebeci Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Ankara University Medical Faculty Cebeci Hospital
During the past decade, Ankara University Medical Faculty Cebeci Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on
average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery
2015-11-06
2029-01-01
Recruiting
126
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
2017-01-13
2023-10-31
Active, not recruiting
818
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2017-05-12
2023-06-30
Active, not recruiting
444
Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes
2017-09-29
2022-04-15
Terminated
23
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
2017-12-22
2023-08-01
Active, not recruiting
1,670
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
2017-06-01
2024-08-01
Suspended
310
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
2017-04-13
2023-11-30
Suspended
175
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ankara University Medical Faculty Cebeci Hospital" #1 sponsor was "Celgene" with 8 trials, followed by "Ankara University" with 2 trials
sponsored, "Allergan" with 1 trials sponsored, "Millennium Pharmaceuticals, Inc." with 1 trials sponsored and "Taiho Oncology, Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara University Medical Faculty Cebeci Hospital"
#1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Ankara University Medical Faculty Cebeci Hospital
According to Clinical.Site data, the most researched conditions in "Ankara University Medical Faculty Cebeci Hospital" are
"Crohn Disease" (3 trials), "Multiple Myeloma" (3 trials), "Beta-thalassemia" (1 trials), "Lymphoma, Large B-Cell, Diffuse" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Ankara University Medical Faculty Cebeci Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Ankara University Medical Faculty Cebeci Hospital
Most popular intervention types in "Ankara University Medical Faculty Cebeci Hospital" are "Drug" (10 trials), "Other" (5 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Dexamethasone" (3 trials), "Ozanimod" (3 trials), "Pomalidomide" (3 trials) and "Luspatercept" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Ankara University Medical Faculty Cebeci Hospital
The vast majority of trials in "Ankara University Medical Faculty Cebeci Hospital" are
14 trials for "All" genders.
Clinical Trials Status at Ankara University Medical Faculty Cebeci Hospital
Currently, there are NaN active trials in "Ankara University Medical Faculty Cebeci Hospital".
undefined are not yet recruiting,
5 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Ankara University Medical Faculty Cebeci Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ankara University Medical Faculty Cebeci Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".